Impact of COVID-19 Pandemic on Frontline Pembrolizumab-Based Treatment for Advanced Lung Cancer

Background: Pembrolizumab monotherapy or pembrolizumab plus chemotherapy has become an important frontline treatment for advanced non-small cell lung cancer (NSCLC). To date, it remains unclear how the coronavirus disease 2019 (COVID-19) pandemic impacted the treatment outcome. Methods: A quasi-expe...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanvetyanon, Tawee, Chen, Dung-Tsa, Gray, Jhanelle E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960275/
https://www.ncbi.nlm.nih.gov/pubmed/36836146
http://dx.doi.org/10.3390/jcm12041611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960275/
https://www.ncbi.nlm.nih.gov/pubmed/36836146
http://dx.doi.org/10.3390/jcm12041611

Ejemplares similares